Cannabis Science Inc (OTCMKTS:CBIS) a U.S. firm specializing in cannabis infusion-based drug development associated consulting announced substantial progress with its subsidiary firm Michigan Green Technologies. John Dalaly, the CEO of Michigan Green Technologies said that the management has continued to work in association with various legislators in Michigan to correct the “Michigan Medical Marihuana Act” of 2008.
He further added that Michigan’s medical cannabis plan has not seen the progress in other states and if suitable legislation can be placed then a well-regulated cannabis economy with integrity can commence to function. The management believes that the company is playing a vital role in this outstanding development. The participants will grow under systematic legal protection. It can be accepted by the law enforcement and the State of Michigan. The citizens will benefit considerably.
Cannabis Sciences stated that since 1987, Dalaly has offered hospital management services to more than 47 hospitals in ten nations that included staffing education, recruiting, lecturing and design of healthcare applications. He has also been with MSU and Southern Mississippi University. The participants together developed an advanced art hospital management solution for third world nations and the ministry of health in Africa, Mexico, Oman, Muscat, Dubai, Iraq and Saudi Kuwait.
Cannabis Science Inc (OTCMKTS:CBIS) also stated that Dalaly developed from 1987 till this time the mobile medical unit’s planned clinic on wheels that has offered outreach plans internationally and nationally. His healthcare knowledge internationally and nationally will be utilized to develop the current Michigan State measures improving economic opportunities within Michigan. The political ties of Dalaly internationally and nationally give him the ability to complete the job. The subsidiary company of Cannabis Sciences has actively got various key members from Michigan to its new Advisory Board. In last trading session, CBIS stock price declined 5.94% to close at $0.0380.